**3. Conclusion**

The development of boron-bearing compound for BNCT has been a vast field of research within medicinal chemistry. New and interesting pharmacophores have been described in order to fulfill the BNCT requirements. Despite this, very few reached the stage of clinical studies, being currently L-BPA and BSH, the only two potential therapeutic agents. However, due to the multidisciplinary approach of the BNCT and the emerging novel structures, we expect with optimism the new developments in the years to come.
